MetLife
Stock Forecast, Prediction & Price Target
MetLife Financial Estimates
MetLife Revenue Estimates
MetLife EBITDA Estimates
MetLife Earnings per Share Estimates
Passed | Analyst forecast | ||||||
---|---|---|---|---|---|---|---|
Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | ||
Revenue
% change YoY
| $71.08B N/A | $69.89B -1.66% | $66.40B -4.99% | Avg: $76.51B Low: $74.05B High: $78.44B avg. 15.22% | Avg: $80.31B Low: $75.42B High: $83.16B avg. 4.96% | ||
Net Income
% change YoY
| $6.85B N/A | $2.35B -65.66% | $1.57B -32.96% | Avg: $6.26B Low: $6.56B High: $7.43B avg. 296.95% | Avg: $6.54B Low: $6.94B High: $8.23B avg. 4.55% | ||
EBITDA
% change YoY
| $6.18B N/A | $3.77B -38.86% | $3.92B 3.89% | Avg: $5.20B Low: $5.04B High: $5.34B avg. 32.72% | Avg: $5.46B Low: $5.13B High: $5.66B avg. 4.96% | ||
EPS
% change YoY
| $7.36 N/A | $2.93 -60.19% | $1.81 -38.22% | Avg: $9.19 Low: $8.61 High: $9.75 avg. 407.79% | Avg: $9.97 Low: $9.11 High: $10.8 avg. 8.43% | ||
Operating Expenses
% change YoY
| $-65.59B N/A | $67.03B 202.20% | $66.40B -0.94% | Avg: $6.69B Low: $6.48B High: $6.86B avg. -89.91% | Avg: $7.03B Low: $6.60B High: $7.28B avg. 4.96% |
FAQ
What is MetLife stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 150.75% in 2025-2026.
We have gathered data from 9 analysts. Their low estimate is 6.56B, average is 6.26B and high is 7.43B.
What is MetLife stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 10.09% in 2025-2026.
We have gathered data from 6 analysts. Their low revenue estimate is $74.05B, average is $76.51B and high is $78.44B.
What is MetLife stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 208.11% in 2025-2026.
We have gathered data from 9 analysts. Their low earnings per share estimate is $8.61, average is $9.19 and high is $9.75.
What is the best performing analyst?
In the last twelve months analysts have been covering MetLife stock. The most successful analyst is Bob Huang.